Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy

J Dtsch Dermatol Ges. 2016 Apr;14(4):427-8. doi: 10.1111/ddg.12858.

[Article in English, German]

Authors

Alexander Thiem¹, Rebecca Mergler¹, Hermann Kneitz¹, Gerhard Weyandt¹, Matthias Goebeler¹, Anja Gesierich¹

Affiliation

¹ Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.

PMID: 27027759
DOI: 10.1111/ddg.12858

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Diagnosis, Differential
Drug Eruptions / etiology*
Drug Eruptions / pathology*
Drug Eruptions / prevention & control
Female
Hidradenitis Suppurativa / chemically induced*
Hidradenitis Suppurativa / pathology*
Hidradenitis Suppurativa / prevention & control
Humans
Indoles / adverse effects*
Indoles / therapeutic use
Melanoma / complications
Melanoma / drug therapy
Middle Aged
Risk Factors
Sulfonamides / adverse effects*
Sulfonamides / therapeutic use
Treatment Outcome
Vemurafenib

Substances

Antineoplastic Agents
Indoles
Sulfonamides
Vemurafenib